BlackRock’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$86.1K Buy
122,993
+42,544
+53% +$45.1K ﹤0.01% 5037
2026
Q1
$131K Buy
80,449
+19,554
+32% +$33.4K ﹤0.01% 4899
2025
Q4
$108K Buy
60,895
+7,181
+13% +$15K ﹤0.01% 4887
2025
Q3
$129K Buy
53,714
+17,141
+47% +$41.6K ﹤0.01% 4775
2025
Q2
$83K Buy
+36,573
New +$91.1K ﹤0.01% 4879
2019
Q2
Hold
0
5059
2019
Q1
Hold
0
5003
2018
Q4
Hold
0
5023
2018
Q3
Hold
0
5053
2018
Q2
Hold
0
5052
2018
Q1
Hold
0
4988
2017
Q4
Hold
0
4984
2017
Q3
Hold
0
5013
2017
Q2
Hold
0
5083
2017
Q1
Hold
0
5064

Other funds holding NSPR

BlackRock's NSPR Position: Q2 2026 in Review

BlackRock increased its InspireMD (NSPR) stake by 53% in Q2 2026, buying an estimated $45.1K and bringing the position to 122,993 shares worth $86.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5037.

BlackRock first reported a position in NSPR in Q2 2025 and has held it in 5 quarters since. The position peaked at $131K in Q1 2026. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • BlackRock held 122,993 shares of InspireMD worth $86.1K as of Q2 2026.
  • BlackRock bought 42,544 InspireMD shares in Q2 2026, an estimated $45.1K.
  • InspireMD made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5037 holding.
  • BlackRock first reported a position in InspireMD in Q2 2025 and has held it in 5 quarters since.
  • BlackRock's InspireMD position peaked at $131K in Q1 2026.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.